Significance

Young Conservationists Creating Positive Change: Announcing the 2024 Global Slingshot Challenge Award Recipients

Retrieved on: 
星期三, 五月 8, 2024

WASHINGTON, May 8, 2024 /PRNewswire/ -- An app to minimize household food waste, a tree-planting robot, and programs to save a rare bird and the bees — these are just some of the solutions from the second year of the Slingshot Challenge, a global call for youth ages 13-18 to propose solutions to the planet's environmental problems. Announced today by the National Geographic Society and the Paul G. Allen Family Foundation, five Top Honors submissions will receive $10,000 each and ten Significant Achievement submissions will receive $1,000 each to advance their projects and continue to explore big ideas.

Key Points: 
  • "As environmental champions, they teach us how to be positive changemakers by bringing fresh perspectives to our communities and creating lasting change for our planet."
  • The 2024 Slingshot Challenge received 2,134 one-minute video submissions from 87 countries.
  • Five Top Honors Award Recipients, noted below, stood out for their notably inquisitive drive to seek knowledge and think critically.
  • These submissions join Slingshot Challenge award recipient alumni in receiving support and funding.

EQS-News: BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates

Retrieved on: 
星期五, 五月 3, 2024

BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates

Key Points: 
  • BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates
    The issuer is solely responsible for the content of this announcement.
  • Media release as at April 26, 2024
    Portfolio of BB Biotech AG as at March 31, 2024
    BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates
    Investor sentiment in the biotech space continues to be shaped by the general interest rate environment.
  • Net profit for the first quarter of 2024 amounted to CHF 260 mn (net loss of CHF 254 mn in prior-year quarter).
  • While activity in the secondary market has already picked up, there have been few biotech IPOs so far this year.

Compelling Coarse Ore Flotation Results Indicate Throughput Upside for Kharmagtai

Retrieved on: 
星期二, 四月 23, 2024

The Eriez HydroFloat test work for evaluating coarse ore flotation has demonstrated excellent results for one of the key uplift scenarios defined in the Kharmagtai Scoping Study1.

Key Points: 
  • The Eriez HydroFloat test work for evaluating coarse ore flotation has demonstrated excellent results for one of the key uplift scenarios defined in the Kharmagtai Scoping Study1.
  • Xanadu’s Executive Chairman and Managing Director, Colin Moorhead said:
    “These results provide strong support for our Scoping Study uplift scenario using coarse ore flotation to improve overall project economics.
  • This uplift is achieved through increasing throughput and accelerating mining and processing rates which ultimately accelerate revenue generation at Kharmagtai.
  • The coarse ore flotation evaluation included head grade analysis and rougher flotation recovery testwork on a composite sample taken from varying deposits, depths, sulphide and alteration types to test coarser grind options.

Qualigen Therapeutics Announces Poster Featuring Positive Early Clinical Experience with QN-302, a Novel First-in-Class G-Quadruplex Experimental Anti-Cancer Drug, at the American Association of Cancer Research (AACR) 2024 Annual Meeting

Retrieved on: 
星期二, 四月 9, 2024

CARLSBAD, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or the “Company,” Nasdaq: QLGN) today announces that a poster featuring its early clinical experience with a novel first-in-class G-Quadruplex experimental anti-cancer drug, QN-302, was presented at the American Association for Cancer Research (AACR) Annual Meeting 2024 held April 5 – 10 in San Diego, California.

Key Points: 
  • CARLSBAD, Calif., April 09, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or the “Company,” Nasdaq: QLGN) today announces that a poster featuring its early clinical experience with a novel first-in-class G-Quadruplex experimental anti-cancer drug, QN-302, was presented at the American Association for Cancer Research (AACR) Annual Meeting 2024 held April 5 – 10 in San Diego, California.
  • Dose escalation initiated (patient #101-004) after three patients successfully completed cycle 1 of the initial dose.
  • Dose escalation will be continued, with more patients being enrolled in the coming months.
  • One patient was withdrawn from study 3/1/2024 after 4 months of stable disease.

KIDRON Capital Assets Announces First Close of Women's Health VC Fund

Retrieved on: 
星期二, 四月 9, 2024

TEL AVIV, Israel, April 9, 2024 /PRNewswire/ -- We are thrilled to announce the successful first close of KIDRON Capital Assets, marking a significant milestone as the premier venture capital fund dedicated to Women's Health. Led by two female General Partners with profound investment and industry expertise in the HealthTech sector, KIDRON is uniquely positioned at the intersection of groundbreaking healthcare innovation and untapped investment potential. Our primary mission is to generate superb returns for our investors by capitalizing on the extensive, yet often overlooked, opportunities within the women's health sector.

Key Points: 
  • TEL AVIV, Israel, April 9, 2024 /PRNewswire/ -- We are thrilled to announce the successful first close of KIDRON Capital Assets, marking a significant milestone as the premier venture capital fund dedicated to Women's Health.
  • Our primary mission is to generate superb returns for our investors by capitalizing on the extensive, yet often overlooked, opportunities within the women's health sector.
  • KIDRON's portfolio encompasses a diverse array of sectors, including medical devices, diagnostics, digital health, therapeutics, and services.
  • Invest in the Future of Women's Health: Partner with KIDRON Capital to Generate High Returns and Make a Difference.

KIDRON Capital Assets Announces First Close of Women's Health VC Fund

Retrieved on: 
星期二, 四月 9, 2024

TEL AVIV, Israel, April 9, 2024 /PRNewswire/ -- We are thrilled to announce the successful first close of KIDRON Capital Assets, marking a significant milestone as the premier venture capital fund dedicated to Women's Health. Led by two female General Partners with profound investment and industry expertise in the HealthTech sector, KIDRON is uniquely positioned at the intersection of groundbreaking healthcare innovation and untapped investment potential. Our primary mission is to generate superb returns for our investors by capitalizing on the extensive, yet often overlooked, opportunities within the women's health sector.

Key Points: 
  • TEL AVIV, Israel, April 9, 2024 /PRNewswire/ -- We are thrilled to announce the successful first close of KIDRON Capital Assets, marking a significant milestone as the premier venture capital fund dedicated to Women's Health.
  • Our primary mission is to generate superb returns for our investors by capitalizing on the extensive, yet often overlooked, opportunities within the women's health sector.
  • KIDRON's portfolio encompasses a diverse array of sectors, including medical devices, diagnostics, digital health, therapeutics, and services.
  • Invest in the Future of Women's Health: Partner with KIDRON Capital to Generate High Returns and Make a Difference.

Jewish Future Promise Reaches Landmark 50,000 Supporters Amidst Global Challenges

Retrieved on: 
星期三, 四月 3, 2024

ATLANTA, April 3, 2024 /PRNewswire/ -- In a monumental milestone in its mission to secure Jewish heritage and values for future generations, The Jewish Future Promise (JFP) today celebrates surpassing 50,000 promisers. In the wake of the October 7 terrorist attacks in Israel and a global rise in antisemitism, this surge of support for JFP underscores the unwavering commitment of individuals, families, and family foundations worldwide to actively supporting Jewish causes and the State of Israel.

Key Points: 
  • ATLANTA, April 3, 2024 /PRNewswire/ -- In a monumental milestone in its mission to secure Jewish heritage and values for future generations, The Jewish Future Promise (JFP) today celebrates surpassing 50,000 promisers.
  • JFP is also proud to share that Karen Cinnamon , esteemed author, podcast host, and founder of the world's largest Jewish wedding media platform, Smashing The Glass, has signed on as the 50,000th signer of the Jewish Future Promise.
  • Known for her contributions to the Jewish community, Cinnamon's involvement amplifies JFP's mission to safeguard and celebrate Judaism and Jewish traditions, culture, and legacy.
  • "The Jewish future is a statement of resilience, transforming shame into pride," Cinnamon said around signing the Jewish Future Promise.

Crypto Prop Firm HyroTrader Seeks Traders: Trade with Up to $1M in Capital

Retrieved on: 
星期四, 二月 22, 2024

HyroTrader, an esteemed crypto prop trading firm headquartered in Prague, is actively seeking talented individuals to join their team and trade with capital ranging from $100,000 to $1 million.

Key Points: 
  • HyroTrader, an esteemed crypto prop trading firm headquartered in Prague, is actively seeking talented individuals to join their team and trade with capital ranging from $100,000 to $1 million.
  • While most brokers, prop trading firms, and crypto platforms profit from the failures of traders, HyroTrader has adopted a different approach.
  • They prioritize assisting crypto traders in gaining access to real capital and professional guidance from experienced mentors and traders.
  • Don't miss this opportunity to trade with substantial capital and unlock your full potential as a crypto trader!

Brown-Forman Announces Launch of Distribution Business in Italy

Retrieved on: 
星期五, 三月 1, 2024

Brown-Forman Corporation (NYSE:BFA,BFB), one of the largest American-owned spirits companies, announces today its plan to distribute its own brands in Italy, effective May 1, 2025.

Key Points: 
  • Brown-Forman Corporation (NYSE:BFA,BFB), one of the largest American-owned spirits companies, announces today its plan to distribute its own brands in Italy, effective May 1, 2025.
  • “We believe setting up our own distribution organization will enable the growth of our brands across all channels in Italy,” said Agnieszka Przybylek, General Manager, Brown-Forman Italy.
  • We believe that the creation of our own distribution business in this market will offer increased consumer focus and prioritization of our brands, empowered by a talented team,” said Yiannis Pafilis, EVP, President of Europe, Brown-Forman.
  • According to IWSR, Italy is among the top five spirits markets in the European Union (excluding the UK) and the leading market for Gin Mare globally.

Brown-Forman Commits Funds to Foundation and Dendrifund

Retrieved on: 
星期五, 三月 1, 2024

Brown-Forman Corporation (NYSE:BFA, BFB) today announced a commitment of $22.5 million to support the efforts of the Brown-Forman Foundation and Dendrifund.

Key Points: 
  • Brown-Forman Corporation (NYSE:BFA, BFB) today announced a commitment of $22.5 million to support the efforts of the Brown-Forman Foundation and Dendrifund.
  • Additionally, the Dendrifund, a nonprofit sustainability seed fund jointly created by Brown-Forman and the Brown family, will receive a $2.5 million donation.
  • Dendrifund serves as a catalyst for collaborative efforts aimed at advancing sustainability within the whiskey industry.
  • Likewise, the ongoing support of Dendrifund underscores the importance the company places on sustainability and innovation within the spirits industry.